Pubblicazioni

Predictive biomarkers for checkpoint inhibitor-based immunotherapy: The Galectin-3 signature in NSCLCs

2019 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Capalbo, C.; Scafetta, G.; Filetti, M.; Marchetti, P.; Bartolazzi, A.

Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma

2019 - ANNALS OF HEMATOLOGY
Serrao, A.; Canichella, M.; De Luca, M. L.; Tartaglia, G.; Annechini, G.; D'Elia, G. M.; Pulsoni, A.

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity

2019 - JOURNAL FOR IMMUNOTHERAPY OF CANCER
Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma